-
1
-
-
0344579025
-
Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix
-
Eldor A, Bar-Ner M, Yahalom J, Fuks Z, Vlodavsky I, (1987) Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix. Semin Thromb Hemost 13: 475-488.
-
(1987)
Semin Thromb Hemost
, vol.13
, pp. 475-488
-
-
Eldor, A.1
Bar-Ner, M.2
Yahalom, J.3
Fuks, Z.4
Vlodavsky, I.5
-
2
-
-
17144415530
-
Site-directed mutagenesis, proteolytic cleavage, and activation of human proheparanase
-
Abboud-Jarrous G, Rangini-Guetta Z, Aingorn H, Atzmon R, Elgavish S, et al. (2005) Site-directed mutagenesis, proteolytic cleavage, and activation of human proheparanase. J Biol Chem 280: 13568-13575.
-
(2005)
J Biol Chem
, vol.280
, pp. 13568-13575
-
-
Abboud-Jarrous, G.1
Rangini-Guetta, Z.2
Aingorn, H.3
Atzmon, R.4
Elgavish, S.5
-
3
-
-
0033028789
-
Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis
-
Hulett MD, Freeman C, Hamdorf BJ, Baker RT, Harris MJ, et al. (1999) Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med 5: 803-809.
-
(1999)
Nat Med
, vol.5
, pp. 803-809
-
-
Hulett, M.D.1
Freeman, C.2
Hamdorf, B.J.3
Baker, R.T.4
Harris, M.J.5
-
4
-
-
0028226536
-
Leucocyte-endothelial interactions and regulation of leucocyte migration
-
Adams DH, Shaw S, (1994) Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 343: 831-836.
-
(1994)
Lancet
, vol.343
, pp. 831-836
-
-
Adams, D.H.1
Shaw, S.2
-
5
-
-
0028324021
-
T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells
-
Blotnick S, Peoples GE, Freeman MR, Eberlein TJ, Klagsbrun M, (1994) T lymphocytes synthesize and export heparin-binding epidermal growth factor-like growth factor and basic fibroblast growth factor, mitogens for vascular cells and fibroblasts: differential production and release by CD4+ and CD8+ T cells. Proc Natl Acad Sci U S A 91: 2890-2894.
-
(1994)
Proc Natl Acad Sci U S A
, vol.91
, pp. 2890-2894
-
-
Blotnick, S.1
Peoples, G.E.2
Freeman, M.R.3
Eberlein, T.J.4
Klagsbrun, M.5
-
6
-
-
0028916622
-
Molecular behavior adapts to context: heparanase functions as an extracellular matrix-degrading enzyme or as a T cell adhesion molecule, depending on the local pH
-
Gilat D, Hershkoviz R, Goldkorn I, Cahalon L, Korner G, et al. (1995) Molecular behavior adapts to context: heparanase functions as an extracellular matrix-degrading enzyme or as a T cell adhesion molecule, depending on the local pH. J Exp Med 181: 1929-1934.
-
(1995)
J Exp Med
, vol.181
, pp. 1929-1934
-
-
Gilat, D.1
Hershkoviz, R.2
Goldkorn, I.3
Cahalon, L.4
Korner, G.5
-
7
-
-
0026722647
-
Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation
-
Vlodavsky I, Eldor A, Haimovitz-Friedman A, Matzner Y, Ishai-Michaeli R, et al. (1992) Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Invasion Metastasis 12: 112-127.
-
(1992)
Invasion Metastasis
, vol.12
, pp. 112-127
-
-
Vlodavsky, I.1
Eldor, A.2
Haimovitz-Friedman, A.3
Matzner, Y.4
Ishai-Michaeli, R.5
-
8
-
-
0032563303
-
Substrate specificity of heparanases from human hepatoma and platelets
-
Pikas DS, Li JP, Vlodavsky I, Lindahl U, (1998) Substrate specificity of heparanases from human hepatoma and platelets. J Biol Chem 273: 18770-18777.
-
(1998)
J Biol Chem
, vol.273
, pp. 18770-18777
-
-
Pikas, D.S.1
Li, J.P.2
Vlodavsky, I.3
Lindahl, U.4
-
10
-
-
0035922067
-
Expression of three extracellular matrix degradative enzymes in bladder cancer
-
Gohji K, Hirano H, Okamoto M, Kitazawa S, Toyoshima M, et al. (2001) Expression of three extracellular matrix degradative enzymes in bladder cancer. Int J Cancer 95: 295-301.
-
(2001)
Int J Cancer
, vol.95
, pp. 295-301
-
-
Gohji, K.1
Hirano, H.2
Okamoto, M.3
Kitazawa, S.4
Toyoshima, M.5
-
11
-
-
0035875082
-
Heparanase expression in primary and metastatic pancreatic cancer
-
Koliopanos A, Friess H, Kleeff J, Shi X, Liao Q, et al. (2001) Heparanase expression in primary and metastatic pancreatic cancer. Cancer Res 61: 4655-4659.
-
(2001)
Cancer Res
, vol.61
, pp. 4655-4659
-
-
Koliopanos, A.1
Friess, H.2
Kleeff, J.3
Shi, X.4
Liao, Q.5
-
12
-
-
70449604674
-
Heparin, heparan sulfate and heparanase in inflammatory reactions
-
Li JP, Vlodavsky I, (2009) Heparin, heparan sulfate and heparanase in inflammatory reactions. Thromb Haemost 102: 823-828.
-
(2009)
Thromb Haemost
, vol.102
, pp. 823-828
-
-
Li, J.P.1
Vlodavsky, I.2
-
13
-
-
84866396748
-
Significance of Heparanase in Cancer and Inflammation
-
(epub ahead of print)
-
Vlodavsky I, Beckhove P, Lerner I, Pisano C, Meirovitz A, et al. (2011) Significance of Heparanase in Cancer and Inflammation. Cancer Microenviron (epub ahead of print).
-
(2011)
Cancer Microenviron
-
-
Vlodavsky, I.1
Beckhove, P.2
Lerner, I.3
Pisano, C.4
Meirovitz, A.5
-
14
-
-
0035999158
-
Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development
-
Vlodavsky I, Goldshmidt O, Zcharia E, Atzmon R, Rangini-Guatta Z, et al. (2002) Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development. Semin Cancer Biol 12: 121-129.
-
(2002)
Semin Cancer Biol
, vol.12
, pp. 121-129
-
-
Vlodavsky, I.1
Goldshmidt, O.2
Zcharia, E.3
Atzmon, R.4
Rangini-Guatta, Z.5
-
15
-
-
0034988696
-
Human heparanase: a molecular determinant of brain metastasis
-
Marchetti D, Nicolson GL, (2001) Human heparanase: a molecular determinant of brain metastasis. Adv Enzyme Regul 41: 343-359.
-
(2001)
Adv Enzyme Regul
, vol.41
, pp. 343-359
-
-
Marchetti, D.1
Nicolson, G.L.2
-
16
-
-
0036672885
-
Heparanase-1 expression is associated with the metastatic potential of breast cancer
-
Maxhimer JB, Quiros RM, Stewart R, Dowlatshahi K, Gattuso P, et al. (2002) Heparanase-1 expression is associated with the metastatic potential of breast cancer. Surgery 132: 326-333.
-
(2002)
Surgery
, vol.132
, pp. 326-333
-
-
Maxhimer, J.B.1
Quiros, R.M.2
Stewart, R.3
Dowlatshahi, K.4
Gattuso, P.5
-
17
-
-
0033810052
-
Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis
-
Friedmann Y, Vlodavsky I, Aingorn H, Aviv A, Peretz T, et al. (2000) Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis. Am J Pathol 157: 1167-1175.
-
(2000)
Am J Pathol
, vol.157
, pp. 1167-1175
-
-
Friedmann, Y.1
Vlodavsky, I.2
Aingorn, H.3
Aviv, A.4
Peretz, T.5
-
18
-
-
18444385059
-
Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma
-
Tang W, Nakamura Y, Tsujimoto M, Sato M, Wang X, et al. (2002) Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma. Mod Pathol 15: 593-598.
-
(2002)
Mod Pathol
, vol.15
, pp. 593-598
-
-
Tang, W.1
Nakamura, Y.2
Tsujimoto, M.3
Sato, M.4
Wang, X.5
-
19
-
-
0034764665
-
Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas
-
Mikami S, Ohashi K, Usui Y, Nemoto T, Katsube K, et al. (2001) Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas. Jpn J Cancer Res 92: 1062-1073.
-
(2001)
Jpn J Cancer Res
, vol.92
, pp. 1062-1073
-
-
Mikami, S.1
Ohashi, K.2
Usui, Y.3
Nemoto, T.4
Katsube, K.5
-
20
-
-
0035127023
-
Expression of heparanase in oral cancer cell lines and oral cancer tissues
-
Ikuta M, Podyma KA, Maruyama K, Enomoto S, Yanagishita M, (2001) Expression of heparanase in oral cancer cell lines and oral cancer tissues. Oral Oncol 37: 177-184.
-
(2001)
Oral Oncol
, vol.37
, pp. 177-184
-
-
Ikuta, M.1
Podyma, K.A.2
Maruyama, K.3
Enomoto, S.4
Yanagishita, M.5
-
21
-
-
2542634131
-
Hypoxia increases heparanase-dependent tumor cell invasion, which can be inhibited by antiheparanase antibodies
-
He X, Brenchley PE, Jayson GC, Hampson L, Davies J, et al. (2004) Hypoxia increases heparanase-dependent tumor cell invasion, which can be inhibited by antiheparanase antibodies. Cancer Res 64: 3928-3933.
-
(2004)
Cancer Res
, vol.64
, pp. 3928-3933
-
-
He, X.1
Brenchley, P.E.2
Jayson, G.C.3
Hampson, L.4
Davies, J.5
-
22
-
-
34447287858
-
Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate
-
Vlodavsky I, Ilan N, Naggi A, Casu B, (2007) Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate. Curr Pharm Des 13: 2057-2073.
-
(2007)
Curr Pharm Des
, vol.13
, pp. 2057-2073
-
-
Vlodavsky, I.1
Ilan, N.2
Naggi, A.3
Casu, B.4
-
23
-
-
20244377541
-
Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor
-
Courtney SM, Hay PA, Buck RT, Colville CS, Phillips DJ, et al. (2005) Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivatives: novel classes of heparanase inhibitor. Bioorg Med Chem Lett 15: 2295-2299.
-
(2005)
Bioorg Med Chem Lett
, vol.15
, pp. 2295-2299
-
-
Courtney, S.M.1
Hay, P.A.2
Buck, R.T.3
Colville, C.S.4
Phillips, D.J.5
-
24
-
-
4143140258
-
Structure-based design of a selective heparanase inhibitor as an antimetastatic agent
-
Ishida K, Hirai G, Murakami K, Teruya T, Simizu S, et al. (2004) Structure-based design of a selective heparanase inhibitor as an antimetastatic agent. Mol Cancer Ther 3: 1069-1077.
-
(2004)
Mol Cancer Ther
, vol.3
, pp. 1069-1077
-
-
Ishida, K.1
Hirai, G.2
Murakami, K.3
Teruya, T.4
Simizu, S.5
-
25
-
-
0023193233
-
Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species
-
Bar-Ner M, Eldor A, Wasserman L, Matzner Y, Cohen IR, et al. (1987) Inhibition of heparanase-mediated degradation of extracellular matrix heparan sulfate by non-anticoagulant heparin species. Blood 70: 551-557.
-
(1987)
Blood
, vol.70
, pp. 551-557
-
-
Bar-Ner, M.1
Eldor, A.2
Wasserman, L.3
Matzner, Y.4
Cohen, I.R.5
-
26
-
-
0034603710
-
An NMR and molecular modeling study of the site-specific binding of histamine by heparin, chemically modified heparin, and heparin-derived oligosaccharides
-
Chuang WL, Christ MD, Peng J, Rabenstein DL, (2000) An NMR and molecular modeling study of the site-specific binding of histamine by heparin, chemically modified heparin, and heparin-derived oligosaccharides. Biochemistry 39: 3542-3555.
-
(2000)
Biochemistry
, vol.39
, pp. 3542-3555
-
-
Chuang, W.L.1
Christ, M.D.2
Peng, J.3
Rabenstein, D.L.4
-
27
-
-
0033565247
-
Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity
-
Parish CR, Freeman C, Brown KJ, Francis DJ, Cowden WB, (1999) Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Cancer Res 59: 3433-3441.
-
(1999)
Cancer Res
, vol.59
, pp. 3433-3441
-
-
Parish, C.R.1
Freeman, C.2
Brown, K.J.3
Francis, D.J.4
Cowden, W.B.5
-
28
-
-
0033027625
-
Aptamers as tools in molecular biology and immunology
-
Famulok M, Mayer G, (1999) Aptamers as tools in molecular biology and immunology. Curr Top Microbiol Immunol 243: 123-136.
-
(1999)
Curr Top Microbiol Immunol
, vol.243
, pp. 123-136
-
-
Famulok, M.1
Mayer, G.2
-
29
-
-
0028869690
-
Diversity of oligonucleotide functions
-
Gold L, Polisky B, Uhlenbeck O, Yarus M, (1995) Diversity of oligonucleotide functions. Annu Rev Biochem 64: 763-797.
-
(1995)
Annu Rev Biochem
, vol.64
, pp. 763-797
-
-
Gold, L.1
Polisky, B.2
Uhlenbeck, O.3
Yarus, M.4
-
30
-
-
0031152065
-
Aptamers as therapeutic and diagnostic reagents: problems and prospects
-
Osborne SE, Matsumura I, Ellington AD, (1997) Aptamers as therapeutic and diagnostic reagents: problems and prospects. Curr Opin Chem Biol 1: 5-9.
-
(1997)
Curr Opin Chem Biol
, vol.1
, pp. 5-9
-
-
Osborne, S.E.1
Matsumura, I.2
Ellington, A.D.3
-
31
-
-
0035966106
-
Tenascin-C aptamers are generated using tumor cells and purified protein
-
Hicke BJ, Marion C, Chang YF, Gould T, Lynott CK, et al. (2001) Tenascin-C aptamers are generated using tumor cells and purified protein. J Biol Chem 276: 48644-48654.
-
(2001)
J Biol Chem
, vol.276
, pp. 48644-48654
-
-
Hicke, B.J.1
Marion, C.2
Chang, Y.F.3
Gould, T.4
Lynott, C.K.5
-
32
-
-
70349898026
-
Reversible cell-specific drug delivery with aptamer-functionalized liposomes
-
Cao Z, Tong R, Mishra A, Xu W, Wong GC, et al. (2009) Reversible cell-specific drug delivery with aptamer-functionalized liposomes. Angew Chem Int Ed Engl 48: 6494-6498.
-
(2009)
Angew Chem Int Ed Engl
, vol.48
, pp. 6494-6498
-
-
Cao, Z.1
Tong, R.2
Mishra, A.3
Xu, W.4
Wong, G.C.5
-
33
-
-
0032896149
-
Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers
-
Floege J, Ostendorf T, Janssen U, Burg M, Radeke HH, et al. (1999) Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am J Pathol 154: 169-179.
-
(1999)
Am J Pathol
, vol.154
, pp. 169-179
-
-
Floege, J.1
Ostendorf, T.2
Janssen, U.3
Burg, M.4
Radeke, H.H.5
-
34
-
-
33745108827
-
Tumor Targeting by an Aptamer
-
Hicke BJ, Stephens AW, Gould T, Chang Y-F, Lynott CK, et al. (2006) Tumor Targeting by an Aptamer. J Nucl Med 47: 668-678.
-
(2006)
J Nucl Med
, vol.47
, pp. 668-678
-
-
Hicke, B.J.1
Stephens, A.W.2
Gould, T.3
Chang, Y.-F.4
Lynott, C.K.5
-
35
-
-
0029114788
-
Potent 2′-amino-2′-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor
-
Jellinek D, Green LS, Bell C, Lynott CK, Gill N, et al. (1995) Potent 2′-amino-2′-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry 34: 11363-11372.
-
(1995)
Biochemistry
, vol.34
, pp. 11363-11372
-
-
Jellinek, D.1
Green, L.S.2
Bell, C.3
Lynott, C.K.4
Gill, N.5
-
36
-
-
0032493654
-
2′-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain
-
Ruckman J, Green LS, Beeson J, Waugh S, Gillette WL, et al. (1998) 2′-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J Biol Chem 273: 20556-20567.
-
(1998)
J Biol Chem
, vol.273
, pp. 20556-20567
-
-
Ruckman, J.1
Green, L.S.2
Beeson, J.3
Waugh, S.4
Gillette, W.L.5
-
37
-
-
74949129241
-
Modification of thiol functionalized aptamers by conjugation of synthetic polymers
-
Da Pieve C, Williams P, Haddleton DM, Palmer RM, Missailidis S Modification of thiol functionalized aptamers by conjugation of synthetic polymers. Bioconjug Chem 21: 169-174.
-
Bioconjug Chem
, vol.21
, pp. 169-174
-
-
da Pieve, C.1
Williams, P.2
Haddleton, D.M.3
Palmer, R.M.4
Missailidis, S.5
-
38
-
-
33750445311
-
DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers
-
Ferreira CS, Matthews CS, Missailidis S, (2006) DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers. Tumour Biol 27: 289-301.
-
(2006)
Tumour Biol
, vol.27
, pp. 289-301
-
-
Ferreira, C.S.1
Matthews, C.S.2
Missailidis, S.3
-
39
-
-
12944304157
-
Selection of aptamers with high affinity and high specificity against C595, an anti-MUC1 IgG3 monoclonal antibody, for antibody targeting
-
Missailidis S, Thomaidou D, Borbas KE, Price MR, (2005) Selection of aptamers with high affinity and high specificity against C595, an anti-MUC1 IgG3 monoclonal antibody, for antibody targeting. J Immunol Methods 296: 45-62.
-
(2005)
J Immunol Methods
, vol.296
, pp. 45-62
-
-
Missailidis, S.1
Thomaidou, D.2
Borbas, K.E.3
Price, M.R.4
-
40
-
-
0035668696
-
Generation of species cross-reactive aptamers using "toggle" SELEX
-
White R, Rusconi C, Scardino E, Wolberg A, Lawson J, et al. (2001) Generation of species cross-reactive aptamers using "toggle" SELEX. Mol Ther 4: 567-573.
-
(2001)
Mol Ther
, vol.4
, pp. 567-573
-
-
White, R.1
Rusconi, C.2
Scardino, E.3
Wolberg, A.4
Lawson, J.5
-
41
-
-
32244436665
-
Non-SELEX selection of aptamers
-
Berezovski M, Musheev M, Drabovich A, Krylov SN, (2006) Non-SELEX selection of aptamers. Journal of the American Chemical Society 128: 1410-1411.
-
(2006)
Journal of the American Chemical Society
, vol.128
, pp. 1410-1411
-
-
Berezovski, M.1
Musheev, M.2
Drabovich, A.3
Krylov, S.N.4
-
42
-
-
0033591465
-
Expanded Sequence Dependence of Thermodynamic Parameters Provides Robust Prediction of RNA Secondary Structure
-
Mathews JS, Zuker M, Turner DH, (1999) Expanded Sequence Dependence of Thermodynamic Parameters Provides Robust Prediction of RNA Secondary Structure. J Mol Biol 288: 910-940.
-
(1999)
J Mol Biol
, vol.288
, pp. 910-940
-
-
Mathews, J.S.1
Zuker, M.2
Turner, D.H.3
-
43
-
-
0002287019
-
Algorithms and Thermodynamics for RNA Secondary Structure Prediction: A Practical Guide
-
In: J Barciszewski BFCC, editors, editor
-
Zuker M, Turner DH, (1999) Algorithms and Thermodynamics for RNA Secondary Structure Prediction: A Practical Guide. In: J Barciszewski BFCC, editors. editor. RNA Biochemistry and Biotechnology: Kluwer Academic Publishers.
-
(1999)
RNA Biochemistry and Biotechnology
-
-
Zuker, M.1
Turner, D.H.2
-
44
-
-
1642327629
-
Targeting of antibodies using aptamers
-
Missailidis S, (2004) Targeting of antibodies using aptamers. Methods Mol Biol 248: 547-555.
-
(2004)
Methods Mol Biol
, vol.248
, pp. 547-555
-
-
Missailidis, S.1
-
45
-
-
0027956706
-
Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues
-
Chuang E, Barnard D, Hettich L, Zhang XF, Avruch J, et al. (1994) Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues. Mol Cell Biol 14: 5318-5325.
-
(1994)
Mol Cell Biol
, vol.14
, pp. 5318-5325
-
-
Chuang, E.1
Barnard, D.2
Hettich, L.3
Zhang, X.F.4
Avruch, J.5
-
46
-
-
0028795913
-
Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase
-
Herrmann C, Martin GA, Wittinghofer A, (1995) Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase. J Biol Chem 270: 2901-2905.
-
(1995)
J Biol Chem
, vol.270
, pp. 2901-2905
-
-
Herrmann, C.1
Martin, G.A.2
Wittinghofer, A.3
-
47
-
-
0027250250
-
Mammalian Ras interacts directly with the serine/threonine kinase Raf
-
Vojtek AB, Hollenberg SM, Cooper JA, (1993) Mammalian Ras interacts directly with the serine/threonine kinase Raf. Cell 74: 205-214.
-
(1993)
Cell
, vol.74
, pp. 205-214
-
-
Vojtek, A.B.1
Hollenberg, S.M.2
Cooper, J.A.3
-
48
-
-
0036163867
-
Anti-(Raf-1) RNA aptamers that inhibit Ras-induced Raf-1 activation
-
Kimoto M, Shirouzu M, Mizutani S, Koide H, Kaziro Y, et al. (2002) Anti-(Raf-1) RNA aptamers that inhibit Ras-induced Raf-1 activation. Eur J Biochem 269: 697-704.
-
(2002)
Eur J Biochem
, vol.269
, pp. 697-704
-
-
Kimoto, M.1
Shirouzu, M.2
Mizutani, S.3
Koide, H.4
Kaziro, Y.5
-
49
-
-
0036463453
-
Novel drug development opportunities for heparin
-
Lever R, Page CP, (2002) Novel drug development opportunities for heparin. Nat Rev Drug Discov 1: 140-148.
-
(2002)
Nat Rev Drug Discov
, vol.1
, pp. 140-148
-
-
Lever, R.1
Page, C.P.2
-
50
-
-
4444362263
-
Glycosaminoglycans and the regulation of allergic inflammation
-
Rose MJ, Page C, (2004) Glycosaminoglycans and the regulation of allergic inflammation. Curr Drug Targets Inflamm Allergy 3: 221-225.
-
(2004)
Curr Drug Targets Inflamm Allergy
, vol.3
, pp. 221-225
-
-
Rose, M.J.1
Page, C.2
-
51
-
-
0042366191
-
Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells
-
McKenzie E, Young K, Hircock M, Bennett J, Bhaman M, et al. (2003) Biochemical characterization of the active heterodimer form of human heparanase (Hpa1) protein expressed in insect cells. Biochem J 373: 423-435.
-
(2003)
Biochem J
, vol.373
, pp. 423-435
-
-
McKenzie, E.1
Young, K.2
Hircock, M.3
Bennett, J.4
Bhaman, M.5
-
52
-
-
36448991500
-
Clustal W and Clustal X version 2.0
-
Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947-2948.
-
(2007)
Bioinformatics
, vol.23
, pp. 2947-2948
-
-
Larkin, M.A.1
Blackshields, G.2
Brown, N.P.3
Chenna, R.4
McGettigan, P.A.5
-
53
-
-
0032539693
-
A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics
-
SantaLucia J Jr, (1998) A unified view of polymer, dumbbell, and oligonucleotide DNA nearest-neighbor thermodynamics. Proc Natl Acad Sci U S A 95: 1460-1465.
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, pp. 1460-1465
-
-
SantaLucia Jr., J.1
-
54
-
-
0042121256
-
Mfold web server for nucleic acid folding and hybridization prediction
-
Zuker M, (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31: 3406-3415.
-
(2003)
Nucleic Acids Res
, vol.31
, pp. 3406-3415
-
-
Zuker, M.1
-
55
-
-
0036712790
-
An aptamer-based quartz crystal protein biosensor
-
Liss M, Petersen B, Wolf H, Prohaska E, (2002) An aptamer-based quartz crystal protein biosensor. Anal Chem 74: 4488-4495.
-
(2002)
Anal Chem
, vol.74
, pp. 4488-4495
-
-
Liss, M.1
Petersen, B.2
Wolf, H.3
Prohaska, E.4
-
56
-
-
1642283653
-
Characterization of antibody-antigen interactions by fluorescence spectroscopy
-
Missailidis S, Brady K, (2004) Characterization of antibody-antigen interactions by fluorescence spectroscopy. Methods Mol Biol 248: 431-441.
-
(2004)
Methods Mol Biol
, vol.248
, pp. 431-441
-
-
Missailidis, S.1
Brady, K.2
|